Atlas Trials

Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT00003496 · TERMINATED

Trial details

NCT number
NCT00003496
Sponsor
Burzynski Research Institute
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer Extensive Stage
Start date
1996-03-07
Primary completion
2004-02-05
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.